
|Videos|March 25, 2014
Prostate Cancer Biopsies
Author(s)E. David Crawford, MD
E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado at Denver, discusses prostate cancer biopsies.
Advertisement
E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado at Denver, discusses prostate cancer biopsies.
Clinical Pearls:
- Normally cancers are diagnosed through PET and CT scans but prostate cancer is diagnosed through biopsies
- Instead of relying solely on results of transrectal biopsies, patients who are deemed low-risk are given mapping biopsies
- Mapping biopsies allow physicians to keep an eye on cancer growth in order to determine if further treatment is needed
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Oncology Update January 2026: New Horizons in Precision Medicine
2
Gemogenovatucel-T Triples Overall Survival in High-Risk HRP Ovarian Cancer
3
CD47 Expression Serves as Predictive Biomarker for HER2+ Breast Cancer
4
Building Better ADCs for GI Cancers: Targets, Timing, and Toxicities
5



















